tru Independence’s Sabra Healthcare REIT SBRA Stock Holding History

tru Independence’s Portfolio SBRA Stock Details SBRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-400	Closed	-$6	–	754
2020 Q2	$6	Buy	+400	New	+$5.26K	﹤0.01%	684

Other funds holding SBRA

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

LPC

Long Pond Capital New York $1.05B AUM 16.49% 1-Year Est. Return

AAMU

APG Asset Management US New York $13B AUM 5.3% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

tru Independence's SBRA Position: Q3 2020 in Review

tru Independence sold out of Sabra Healthcare REIT (SBRA) in Q3 2020, closing a stake of 400 shares — an estimated $6 sold.

tru Independence first reported a position in SBRA in Q2 2020 and held it in 1 quarter. The position peaked at $6 in Q2 2020. 318 funds tracked by Wall St. Rank hold SBRA as of Q3 2020.

tru Independence reported no remaining Sabra Healthcare REIT position as of Q3 2020 after selling out during the quarter.
tru Independence sold 400 Sabra Healthcare REIT shares in Q3 2020, an estimated $6.
tru Independence first reported a position in Sabra Healthcare REIT in Q2 2020 and held it in 1 quarter.
tru Independence's Sabra Healthcare REIT position peaked at $6 in Q2 2020.
318 funds tracked by Wall St. Rank held Sabra Healthcare REIT as of Q3 2020.

Based on tru Independence's 13F filing for Q3 2020, filed 19 Nov 2020.